SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-061212
Filing Date
2024-05-16
Accepted
2024-05-16 17:19:29
Documents
2
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1633
2 EX-24.1 alrn-ex24_1.htm EX-24.1 10865
  Complete submission text file 0000950170-24-061212.txt   14026
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ORGANOGENESIS INC. 85 DAN ROAD CANTON MA 02021
Business Address
Cunningham Timothy M. (Reporting) CIK: 0001757426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 24956796